E-DRUG Archives (by date)

• Thread Index

April 30, 2005
• [e-drug] GPP - Good Publication Practice (for drug companies)
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Doctors prescribing heavily influenced by DTCA (4)
  • From: "Joel Lexchin" <joel.lexchin@utoronto.ca>
• [e-drug] RFI: Availability of ACT?
  • From: "Libby Levison" <libby@theplateau.com>
• [e-drug] pharmacist v/s physician?
  • From: "sushobhit singh" <pharmacist_in@yahoo.com>
April 29, 2005
• [e-drug] Doctors prescribing heavily influenced by DTCA (3)
  • From: "Dr Peter R Mansfield" <peter.mansfield@adelaide.edu.au>
• [e-drug] Doctors prescribing heavily influenced by DTCA (2)
  • From: "Parrish, Richard" <RParrish@su.edu>
• [e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare(6)
  • From: "Atieno Ojoo" <atisojoo@yahoo.co.uk>
• [e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare(5)
  • From: "Emeje Martins" <martinsemeje@yahoo.com>
• [e-drug] Doctors prescribing heavily influenced by DTCA
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare(4)
  • From: "Robert Nyarango" <rnyarango@gerties.org>
April 28, 2005
• [e-drug] Antibiotics still a problem (2)
  • From: "Anibal Sosa, MD" <anibal.sosa@tufts.edu>
• [e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare (3)
  • From: "Atieno Ojoo" <atisojoo@yahoo.co.uk>
• [e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare (2)
  • From: "Billy Futter" <B.Futter@ru.ac.za>
• [e-drug] Health Product Innovation in Developing Countries
  • From: "Anatole Krattiger" <anatole@bioDevelopments.org>
April 27, 2005
• [e-drug] Send an abstract to the 20-22 June SEAM Conference in Accra!
  • From: "Keith Johnson" <kjohnson@msh.org>
• [e-drug] Gilead licenses Aspen Pharmacare To Produce ARVs
  • From: "Leela McCullough" <leela@healthnet.org>
• [e-drug] RFI: STI clinic supply management
  • From: "Carolyn Green" <cgreen@aidsalliance.org>
• [e-drug] Global Fund changes quality assurance rules
  • From: "E-Drug" <e-drug@healthnet.org>
April 26, 2005
• [e-drug] Economist: Seeking a cure for legal headaches
  • From: "E-DRUG" <e-drug@healthnet.org>
• [e-drug] Med-reps and irrational medicine use in sub-Saharan Africa (5)
  • From: "Kevin Outterson" <Kevin.Outterson@mail.wvu.edu>
April 25, 2005
• [e-drug] Med-reps and irrational medicine use in sub-Saharan Africa(5)
  • From: "Atieno Ojoo" <atisojoo@yahoo.co.uk>
• [e-drug] antibiotics still a problem
  • From: "P. Swarts" <swartsp@doh.ofs.gov.za>
• [e-drug] WHO database of ARV registration in countries
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
April 23, 2005
• [e-drug] Med-reps and irrational medicine use in sub-Saharan Africa (4)
  • From: "sushobhit singh" <pharmacist_in@yahoo.com>
April 22, 2005
• [e-drug] Med-reps and irrational medicine use in sub-Saharan Africa(3)
  • From: "Dardane Arifaj-Blumi" <dardanearifaj@hotmail.com>
• [e-drug] USA trying to block abortion pills in new WHO EML? (3)
  • From: "Norman Lufesi" <nlufesi@yahoo.com>
• [e-drug] PEPFAR, Global Health Corps & brain drain
  • From: "Libby Levison" <libby@theplateau.com>
April 21, 2005
• [e-drug] USA trying to block abortion pills in new WHO EML? (2)
  • From: "Atieno Ojoo" <atisojoo@yahoo.co.uk>
April 20, 2005
• [e-drug] Med-reps and irrational medicine use in sub-Saharan Africa (2)
  • From: "Dr Peter R Mansfield" <peter.mansfield@adelaide.edu.au>
• [e-drug] Motivating Pharmacists for Enhanced Contribution in Healthcare
  • From: "Kibumba George" <kibumba@yahoo.com>
• [e-drug] Med-reps and irrational medicine use in sub-Saharan Africa
  • From: "Olutayo Adetokunbo" <oamoronkeji@yahoo.com>
• [e-drug] Tinidazole versus Metronidazole for H pylori eradication
  • From: "Olutayo Adetokunbo" <oamoronkeji@yahoo.com>
• [e-drug] Economist: One World Health and neglected diseases
  • From: "Libby Levison" <libby@theplateau.com>
• [e-drug] Employment opportunities with Axios Group
  • From: "Joanna Ignaszewska" <ignaszewskaj@axiosint.com>
April 19, 2005
• [e-drug] WHO/EDM-UNICEF Technical Briefing Seminar September 2005
  • From: "Laing, Richard" <laingr@who.int>
• [e-drug] BMJ: Say no to the free lunch
  • From: "E-Drug" <e-drug@healthnet.org>
April 17, 2005
• [e-drug] USA trying to block abortion pills in new WHO EML?
  • From: "E-Drug" <e-drug@healthnet.org>
April 15, 2005
• [e-drug] Institute for OneWorld Health receives grant for visceral leishmaniasis
  • From: "Leela McCullough" <leela@healthnet.org>
April 13, 2005
• [e-drug] More transparency about counterfeits needed
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] EMEA warns against tenofovir-didanosine co-administration
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] UK: all Clinical Trials to be published before registration
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] FDA warns against off-label use of antipsychotics in the elderly
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] MSF conference London 8 June innovation for neglected diseases
  • From: "Mai Do" <mdo@paris.msf.org>
April 12, 2005
• [e-drug] Clinical Pearls from The Cochrane Library
  • From: "Ciprian Jauca" <jauca@ti.ubc.ca>
• [e-drug] Training course: Supply Chain Management HIV/AIDS Medicines & Supplies
  • From: "Clarisse Audrey Morris" <camorris@ida.nl>
April 11, 2005
• [e-drug] Malaria chemoprophylaxis (6)
  • From: "Bill Arnold" <farmacia@bigpond.net.au>
• [e-drug] Pfizer fluconazole programme failing in Dominican Republic
  • From: "Eugene Schiff" <iecs96i@aol.com>
April 10, 2005
• [e-drug] HIVNET 012 Uganda nevirapine study validated by independent analysis
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Lancet article supports generic ARVs (2)
  • From: "Norman Nyazema" <nznyazema@yahoo.com>
April 08, 2005
• [e-drug] Ivernmectin availability
  • From: "James B. Russo" <JBRusso@aol.com>
• [e-drug] Mefloquine as malaria chemoprophylaxis (5)
  • From: "Dr S Toovey" <toovey@travelclinic.co.za>
• [e-drug] Lancet article supports generic ARVs
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] RFI: doxycycline agelimits and quinine malaria dosages (2)
  • From: "jude ike nwokike" <monkiyke@yahoo.com>
• [e-drug] Mefloquine as malaria chemoprophylaxis (3)
  • From: "Dr S Toovey" <toovey@travelclinic.co.za>
• [e-drug] Mefloquine as malaria chemoprophylaxis (2)
  • From: " Andy Gray " <andy@gray.za.net>
• [e-drug] Mefloquine as malaria chemoprophylaxis (4)
  • From: "Rina Meyer" <FKLCLM@puknet.puk.ac.za>
• [e-drug] Source of generic ivermectin? (5)
  • From: "Murtada Sesay" <msesay@unicef.org>
• [e-drug] course: Management of Medicines in International Health
  • From: "Tanja Schwering" <tanja.schwering@inwent.org>
• [e-drug] RFI: Drug Revolving Fund Evaluation criteria
  • From: "nilakantha bhoi" <nilachakra_333@yahoo.co.in>
April 07, 2005
• [e-drug] FDA action on Cox-2 NSAIDs; valdexocib withdrawal
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] RFI: doxycycline agelimits and quinine malaria dosages
  • From: "Kae" <kaecherie@yahoo.co.uk>
• [e-drug] Mefloquine as malaria chemoprophylaxis
  • From: "kae" <kaecherie@yahoo.co.uk>
• [e-drug] Draft Sri Lankan National Drug Policy for comments
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Source of generic ivermectin? (4)
  • From: "David Veazey / AFEW" <david_veazey@afew.org>
• [e-drug] UK Parliament: new critical report on pharm industry (2)
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] Handbook of drug discontinuation
  • From: "Staffan Svensson" <staffan.svensson@pharm.gu.se>
April 06, 2005
• [e-drug] UK Govt on Good Pharmaceutical Industry practice
  • From: "E-Drug" <e-drug@healthnet.org>
• [e-drug] The Global Fund granting system is failing
  • From: "Brook Baker" <B.Baker@neu.edu>
• [e-drug] IDA Managing Drug Supply Course 29 May-11 June
  • From: "Andrew Marshall" <amarshall@ida.nl>
April 05, 2005
• [e-drug] Source of generic ivermectin? (3)
  • From: "Horst Herb" <subscriptions@gnumed.net>
• [e-drug] Source of generic ivermectin? (2)
  • From: "Atieno Ojoo" <atisojoo@yahoo.co.uk>
• [e-drug] New WHO Prequalification list for AIDS drugs
  • From: "Carmen Perez" <carmen.perez@paris.msf.org>
• [e-drug] Framework contracts for drug procurement (2)
  • From: "AEDES-ZIM" <aedes@zol.co.zw>
• [e-drug] UK Parliament: new critical report on pharm industry
  • From: "Wilbert Bannenberg" <wjb@wxs.nl>
• [e-drug] Framework contracts for drug procurement
  • From: "Rob Verhage" <verhager@cq-link.sr>
• [e-drug] Source of generic ivermectin?
  • From: "Beverley Snell" <bev@burnet.edu.au>
April 04, 2005
• [e-drug] RFI: Medicines for children under 5 (1)
  • From: "Essential Drugs Project" <edp@gn.apc.org>
April 01, 2005
• [e-drug] Cost effectiveness and cost benefit analysis (4)
  • From: "Akunne Anayo" <akunneaf@netscape.net>
• [e-drug] Cost effectiveness and cost benefit analysis (3)
  • From: "Kees de Joncheere" <cjo@euro.who.int>
• [e-drug] E-conference: Prescription Audit- A Case Study from India
  • From: "reinhard huss" <reinhard.huss@urz.uni-heidelberg.de>
March 31, 2005
• [e-drug] RFI: Medicines for children under 5
  • From: "Atieno Ojoo" <atisojoo@yahoo.co.uk>
• [e-drug] Conference: Risks of counterfeits in importation(2)
  • From: "Donald Light" <dlight@Princeton.EDU>